How can academia contribute to drug development?

March 11, 2016

With the monolithic in-house model of drug development breaking down, can adademic research units contribute new drug candidates?

 

The University of Sussex certainly thinks so. The Sussex Drug Discovery Centre (SDDC) is a fully integrated group of drug discovery scientists, equipped with industry standard equipment and capabilities, based at the University of Sussex. Senior staff are all ex-industry and the centre is organised to identify and develop new drug candidates.

 

With a focus on CNS, oncology and respiratory, the team has aleady pioneered strong allegiances with pharma companies and the lead compound should be ready for out-licensing within 18 months, or so. The interesting thing about SDDC is the integration of academic research excellence (the university), with pharma-savvy senior scientists (four professors).

 

So perhaps there is an alternative to VC-funded startups based in Boston, Massachusetts...

 

 

 

 

Please reload

Featured Posts

I'm busy working on my blog posts. Watch this space!

Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square